AB&B BIO-TECH-B (02627) News

H-share announcements | Dama Entertainment issues profit alert, expecting annual net profit attributable to shareholders to be no less than 700 million yuan

Guofu Quantum and Yitusheng Technology have entered into a strategic cooperation memorandum of understanding, planning to jointly establish a quantum computing center in Hong Kong; Dama Entertainment announced a profit alert, expecting its annual net profit attributable to shareholders to be no less than 700 million yuan.

Zhitong FinanceMay 11 09:00

Zhonghui Bio-B (02627): China's Center for Drug Evaluation Approves IND Application for MRNA RSV Vaccine

Zhonghui Bio-B (02627) announced that following the group's receipt of approval from the United States Food and Drug Administration for its new drug clinical trial application submitted in the United States on November 7, 2025, the Center for Drug Evaluation of the National Medical Products Administration has approved the IND application for the group's self-developed mRNA RSV vaccine candidate.

Zhitong FinanceMay 8 20:57

Zhonghui Bio-B (02627) received resumption guidelines from the Stock Exchange and remains suspended.

Zhonghui Bio-B (02627) announced that on April 24, 2026, the company received a letter from the Stock Exchange, which outlined the following guidance regarding the resumption of trading of the company’s shares: (i) Conduct an appropriate independent forensic investigation into fund investments (including initial and reinvestments), consulting fees, and any other investments or payments of a similar nature or raising similar concerns, assess their impact on the company’s business operations and financial condition, disclose the findings, and take appropriate remedial actions.

Zhitong FinanceApr 29 18:03

China Wisdom Biotech-B (02627) has appointed Bai Chun as its new auditing firm.

Zhonghui Bio-B (02627) announced that, in light of the vacancy in the position of the company’s auditor following the resignation of Deloitte • Guan Huang Chen Fang & Co. (Deloitte), the board of directors has resolved, upon the recommendation of the audit committee, to appoint Bok Chun Certified Public Accountants Limited (Bok Chun) as the new auditor of the company. The appointment will take effect from the date of approval by the shareholders at the company’s shareholders’ meeting and will continue until the conclusion of the company’s next annual general meeting (Proposed Appointment of Auditor).

Zhitong FinanceApr 24 22:29

Zhonghui Bio-B (02627.HK) intends to nominate Lei Meijia as an independent non-executive director candidate.

Gelonghui, April 24th - ZH Bio-B (02627.HK) announced that the board has proposed (i) nominating Lei Meijia as a candidate for independent non-executive director of the second board; (ii) appointing Lei as a member of the board’s audit committee; and (iii) making certain amendments to the company's articles of association.

Gelonghui FinanceApr 24 22:28

Zhonghui Bio-B (02627.HK): Proposal to Dissolve the Board of Supervisors

Gelonghui, April 19th - ZH Bio-B (02627.HK) announced that, in accordance with the 'Company Law of China' and other applicable laws, regulations, and normative documents, and taking into account the actual situation of the company, the board of directors proposed to dissolve the board of supervisors, subject to shareholder review and approval. The functions and powers of the board of supervisors as stipulated under the 'Company Law of China' will be assumed by the company’s audit committee. Accordingly, the positions of the current supervisors will be terminated, and the rules of procedure for the board of supervisors meetings will be abolished.

Gelonghui FinanceApr 19 19:45

ZH Bio-B (02627) Adjusts Members of Strategic Committee

Zhonghui Bio-B (02627) announced that the board of directors has reviewed and approved the adjustment of the members of the company’s board strategic committee, effective as of the date of board approval. The adjusted membership is as follows: Chairman: Mr. An Youcai; Members: Mr. He Yiming, Mr. Li Xiangming.

Zhitong FinanceApr 19 19:38

The first and only trivalent influenza virus subunit vaccine for the entire population is steadily advancing in nationwide procurement, contributing to global influenza prevention and control efforts by 2026!

Recently, Jiangsu Zhonghui Yuan Tong Biotechnology Co., Ltd. (referred to as 'Zhonghui Biotech', 02627) has announced further positive developments in the market.

Zhitong FinanceApr 14 16:29

Zhonghui Biotech (02627): Monkeypox mRNA vaccine application accepted, partnering with Chongqing CDC to enhance innovation capabilities

Recently, Zhonghui Bio (02627) has achieved several breakthrough advancements in corporate innovation and development. The clinical trial application for its self-developed Class I new drug, a monkeypox mRNA vaccine, has been accepted by the Center for Drug Evaluation under the National Medical Products Administration of China.

Zhitong FinanceApr 1 08:33

Zhonghui Bio-B (02627) has suspended trading as of April 1, pending the release of its 2025 annual results.

Zhonghui Bio-B (02627) announced that trading of the company’s shares will be suspended on the Stock Exchange at 9:00 a.m. on Wednesday, April 1, 2026, until the company releases its 2025 annual results.

Zhitong FinanceApr 1 08:29

AB&B BIO-TECH-B: INSIDE INFORMATION:(1) DELAY IN PUBLICATION OF ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2025;(2) POSTPONEMENT OF BOARD MEETING; AND(3) SUSPENSION OF TRADING

HKEXApr 1 08:14 · Announcements

This Week's Hong Kong Stock Gainers | Xunce Technology surged over 28% this week, with massive API calls continuing to fuel the 'First Token Stock'; Ganfeng Lithium rose more than 27% as lithium carbonate prices stabilized and rebounded; CStone Pharmaceut

This week, the Hang Seng Index fell by a cumulative 1.29%, closing at 24,951.88 points; during the same period, the Hang Seng Tech Index dropped by a cumulative 1.94%, closing at 4,778.01 points; the H-share Index also declined by a cumulative 1.4%, closing at 8,453.77 points.

Futu NewsMar 28 11:08

Top Performers in Hong Kong Stocks This Week | Xun Ce Technology surged over 30% week-on-week, with massive API calls continuing to drive the leading Token stock; FIT HON TENG rose over 28%, driven by strong AI demand boosting high earnings growth; Bright

This week, the Hang Seng Index fell by a cumulative 0.74% to close at 25,277.32 points; during the same period, the Hang Seng Tech Index dropped by a cumulative 2.12% to 4,872.38 points; the Hang Seng China Enterprises Index also declined by a cumulative 1.12% to 8,574.07 points over the same timeframe.

Futu NewsMar 21 11:08

Ab&B Bio-Tech Sets Board Meeting to Approve 2025 Results and Weigh Final Dividend

TipRanksMar 19 17:41

AB&B BIO-TECH-B: DATE OF BOARD MEETING

HKEXMar 19 17:08 · Announcements

H Shares Announcement Highlights | Sinopec Engineering Group Releases Annual Results: Shareholder Net Profit of 1.798 Billion Yuan, Down 27.1% Year-on-Year

Hebao-B (02256): The first patient dosing has been completed in the Phase II clinical trial for Epagorutinib in combination with targeted immunotherapy as a first-line treatment for advanced hepatocellular carcinoma; China Carbon Neutralization (01372): Xun Lithium Technology and Hubei Liming Lithium Industry have signed a strategic cooperation agreement.

Zhitong FinanceMar 16 09:07

Hong Kong Stock Announcements Digest | China Resources Power's photovoltaic sales volume increased by over 50% in the first two months; Southern Manganese Industry's annual revenue exceeded HKD 6.3 billion.

①China Resources Power's photovoltaic electricity sales increased by over 50% in the first two months. What is the overall scale? ②Southern Manganese Industry's annual revenue exceeded HKD 6.3 billion. What was the growth rate?

cls.cnMar 13 20:25

A Powerful Alliance! Zhonghui Bio-B (02627) Partners with Walvax Bio to Launch the Third-Generation Flu Vaccine into New Overseas Markets

Zhonghui Bio-B (02627) and Walvax Bio (300142.SZ) officially signed a strategic cooperation agreement for the overseas market of influenza virus subunit vaccines in Taizhou.

Zhitong FinanceMar 13 18:13

Hong Kong Stock Market Midday Review | The Hang Seng Index rose 0.08% in the morning session, with CATL surging over 8%.

CATL (3750.HK) surged over 8% again, with annual net profit increasing by more than 40%. Jefferies noted that the results significantly exceeded expectations.

Zhitong FinanceMar 11 12:00

Zhonghui Biotech rose as the company was officially added to the Hong Kong Stock Connect list, with its innovative technology approach gaining international recognition.

ZH Bio-B (02627) surged over 19% once again. As of the latest report, it was up 14.67%, trading at HKD 68.8 with a turnover of HKD 50.6877 million.

Zhitong FinanceMar 11 10:17